cmAngio® vs TOMTEC-ARENA
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to leverage existing mammography data for early cardiovascular health risk assessment in women. This AI-powered tool is ideal for clinics and hospitals focused on women's health and preventative cardiology, enabling the detection and visualization of Breast Arterial Calcifications (BAC) without additional radiation or procedures. It integrates seamlessly to provide valuable insights into potential cardiac concerns from routine mammograms.
View cmAngio® →Choose TOMTEC-ARENA if…
Choose TOMTEC-ARENA if your institution requires a highly versatile, multimodality, and vendor-neutral platform for advanced medical image analysis, quantification, and structured reporting across cardiology and radiology. This solution is best suited for environments needing comprehensive AI-powered measurement automation, web-based diagnostic workflows, and scalable data management for 2D, 3D, and 4D imaging data. It offers flexible deployment options and tailored licensing for various practice sizes, from private practices to large hospital networks.
View TOMTEC-ARENA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | TOMTEC-ARENA |
|---|---|---|
| Pricing | Paid, out-of-pocket | Unknown |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®Tool A emphasizes a 'quick and easy installation (less than an hour)' and compatibility with any DICOM-compliant viewer, suggesting minimal disruption to existing workflows. Its focused task of BAC detection with a 'scorecard' likely offers a streamlined user experience for its specific application. Tool B, while offering web-based workflows, is a broader multimodality platform which may imply a steeper learning curve for its extensive features.
Clinical Value
cmAngio®Tool A offers a distinct and novel clinical value by leveraging existing mammography data for early cardiovascular risk assessment through Breast Arterial Calcification (BAC) detection, without requiring additional procedures or radiation. This addresses a specific, under-recognized clinical gap in women's health. Tool B provides broad advanced image analysis and quantification across multiple modalities, which is valuable for efficiency, but less uniquely positioned for a new clinical insight.
Pricing & Value
TOMTEC-ARENAWhile both tools require direct vendor contact for pricing, Tool B provides more transparency regarding its flexible licensing options, including concurrent user licenses, automated archiving, and 'small business' pricing models. This suggests a more adaptable and potentially cost-effective solution for a wider range of healthcare providers. Tool A mentions limited-time offers for no-cost implementation, but lacks details on long-term pricing structures.
Enterprise Readiness
TOMTEC-ARENATool B offers robust deployment options including on-premise, cloud-hybrid, and client-server networks, along with explicit mentions of DICOM connectivity, PACS/EMR integration, and automated archiving. This comprehensive approach to integration and data management makes it highly suitable for diverse enterprise environments. While Tool A is HIPAA-compliant and cybersecure, its inferred cloud-based deployment and less detailed integration features make Tool B more versatile for enterprise adoption.
Innovation
cmAngio®Tool A demonstrates higher innovation by applying AI to detect Breast Arterial Calcifications (BAC) on mammograms for cardiovascular risk assessment, effectively repurposing existing imaging data for a new and significant clinical insight. This represents a novel approach to identifying women at risk for coronary heart disease. While Tool B offers advanced AI-powered analysis and web-based workflows, its core functionality of multimodality image analysis is a more established area within medical imaging.
Support & Docs
TOMTEC-ARENATool B explicitly outlines its support structure, mentioning 'premium TOMTEC service with an Up-to-Date maintenance contract' and an 'extensive Educational Program' including eLearning modules and a 'TOMTEC ACADEMY'. This indicates a well-defined and comprehensive approach to customer support and ongoing education. Tool A's provided information does not detail specific support offerings or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | TOMTEC-ARENA |
|---|---|---|
| Primary Function | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows. |
| Company | CureMetrix | TOMTEC Imaging Systems GmbH |
| Key AI Functionality | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard. | AI-based measurement automation and data analytics; Advanced quantification for various medical specialties. |
| Supported Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Radiology |
| Image Data Support | Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Compatible with any DICOM-compliant viewer. | Support for 2D, 3D, and 4D image data; DICOM connectivity. |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and TOMTEC-ARENA.